EPISODE · Aug 29, 2022 · 35 MIN
The Future of MRD in Multiple Myeloma Treatment Decision Making
from Oncology Data Advisor · host i3 Health
In this interview, Oncology Data Advisor Editorial Board member Dr. Rahul Banerjee speaks with Dr. Ben Derman, Assistant Professor of Medicine at the University of Chicago, about his research regarding measurable residual disease (MRD) detection in multiple myeloma and its potential role in guiding treatment decisions.
Embed this episode
NOW PLAYING
The Future of MRD in Multiple Myeloma Treatment Decision Making
0:00
35:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Data Advisor?
This episode is 35 minutes long.
When was this Oncology Data Advisor episode published?
This episode was published on August 29, 2022.
Can I download this Oncology Data Advisor episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!